Improving understanding of benign prostate hyperplasia using mouse models
Official title: Validating Mouse Models of Prostatic Hyperplasia
Funded at Endeavor Health Clinical Operations · NIH-11145144 · Data updated 2026-11-12
This study is looking at special mouse models to help us understand benign prostatic hyperplasia (BPH), a common issue for men, so we can find better ways to treat it.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Endeavor Health Clinical Operations NIH-funded |
| Lab location | 1 site (Evanston, United States) |
| Project start | August 1, 2024 |
| Project end | May 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $41,000 |
| NIH project number | 5P20DK140417-02 |
| Project ID | NIH-11145144 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are men experiencing symptoms of benign prostatic hyperplasia or those at risk of developing the condition.
✕Less likely to help
Patients with prostate cancer or other severe urological conditions may not benefit from this research.
What this research studies
This research focuses on validating mouse models that mimic benign prostatic hyperplasia (BPH), a common condition affecting men. By using these models, researchers aim to better understand the biological mechanisms behind BPH and develop potential treatments. The project involves collaboration among early-stage investigators who will receive support and resources to enhance their research capabilities. The findings could lead to improved therapeutic strategies for managing BPH in patients.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for benign prostatic hyperplasia, improving quality of life for affected patients.
How similar studies have gone: Previous research has shown promise in using animal models to study benign prostatic hyperplasia, indicating that this approach has potential for success.
Where this research is happening
-
Endeavor Health Clinical Operations
Evanston, United States Active
Researchers
- Principal investigator: Hayward, Simon W — Endeavor Health Clinical Operations
- Study coordinator: Hayward, Simon W
Related research
Other NIH-funded projects on the same topics.
-
Enhanced MRI to detect brain metastases
This project uses a new contrast MRI method to make very small brain metastases and leptomeningeal disease easier to see in adults with cancer.
-
Understanding how families’ circumstances affect a child’s language and thinking development
This project looks at how a child’s early environment and SES shapes language and cognitive development through biological and psychological pathways.
-
TNF blockers and enlarged prostate in aging men
A study explores whether blocking TNF can help reduce symptoms and enlargement of the prostate in men with BPH/LUTS.
-
Why menstrual pain becomes chronic pelvic pain
We will follow young women with menstrual pain, including those with bladder sensitivity, to learn who develops ongoing pelvic pain and which early signs predict it.
-
Fat-rich TREM2+ immune cells that may drive an enlarged prostate
This project looks at whether fat-filled immune cells called TREM2+ macrophages cause prostate enlargement and if targeting them could help men with BPH.
-
How cholesterol and tiny fat droplets affect brain cells in Alzheimer's
This project explores whether abnormal cholesterol and small fat droplets inside nerve cells harm people with Alzheimer's or those at higher genetic risk (for example, APOE4 carriers) and whether targeting these problems could protect the brain.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.